Adamis Pharmaceuticals reported -7913290 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Adamis Pharmaceuticals ADMP:US -7913290 3.19K
Adma Biologics ADMA:US $ -14815070 1.62M
Brainstorm Cell Therapeutics BCLI:US $ -5475000 737K
Cara Therapeutics CARA:US $ -27911000 5.61M
Cerulean Pharma CERU:US $ -8400450 1.14M
GlaxoSmithKline GSK:LN 2.42B 724M
Glaxosmithkline GSK:US 2.42B 724M
Merk MRK:US $ 5059M 207M
Pfizer PFE:US $ 9995M 4136M